SHEPHERD WEALTH MANAGEMENT Ltd LIABILITY Co Boosts Holdings in Axon Enterprise, Inc $AXON

SHEPHERD WEALTH MANAGEMENT Ltd LIABILITY Co lifted its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 70.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,829 shares of the biotechnology company’s stock after purchasing an additional 1,165 shares during the period. Axon Enterprise comprises about 1.4% of SHEPHERD WEALTH MANAGEMENT Ltd LIABILITY Co’s holdings, making the stock its 18th largest position. SHEPHERD WEALTH MANAGEMENT Ltd LIABILITY Co’s holdings in Axon Enterprise were worth $2,030,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the company. Stone House Investment Management LLC acquired a new position in Axon Enterprise in the 3rd quarter valued at about $29,000. Hemington Wealth Management increased its holdings in Axon Enterprise by 70.8% during the 2nd quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 17 shares in the last quarter. Whipplewood Advisors LLC raised its position in shares of Axon Enterprise by 192.9% during the 2nd quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock worth $34,000 after purchasing an additional 27 shares during the last quarter. Darwin Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the second quarter valued at $37,000. Finally, Root Financial Partners LLC purchased a new position in Axon Enterprise in the 3rd quarter valued at about $34,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price of $551.92, for a total transaction of $5,519,200.00. Following the completion of the transaction, the chief executive officer owned 3,110,997 shares in the company, valued at $1,717,021,464.24. The trade was a 0.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Jennifer H. Mak sold 1,134 shares of the business’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $600.00, for a total transaction of $680,400.00. Following the transaction, the chief accounting officer directly owned 13,740 shares of the company’s stock, valued at approximately $8,244,000. This trade represents a 7.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 65,540 shares of company stock worth $39,201,438. 4.40% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on AXON shares. UBS Group reduced their target price on Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 5th. Needham & Company LLC restated a “buy” rating and set a $870.00 price objective on shares of Axon Enterprise in a research note on Wednesday, September 24th. Royal Bank Of Canada began coverage on shares of Axon Enterprise in a report on Monday, November 17th. They set an “outperform” rating and a $860.00 price target for the company. The Goldman Sachs Group dropped their price target on shares of Axon Enterprise from $940.00 to $800.00 and set a “buy” rating on the stock in a research note on Wednesday, November 5th. Finally, Piper Sandler decreased their price objective on shares of Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating for the company in a research report on Wednesday, November 5th. Fourteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $802.71.

Axon Enterprise Stock Up 0.0%

NASDAQ:AXON opened at $591.15 on Thursday. The company has a debt-to-equity ratio of 0.57, a quick ratio of 2.89 and a current ratio of 3.12. The company has a market capitalization of $46.65 billion, a price-to-earnings ratio of 187.07, a price-to-earnings-growth ratio of 135.74 and a beta of 1.40. Axon Enterprise, Inc has a one year low of $469.24 and a one year high of $885.91. The stock has a 50-day simple moving average of $602.67 and a 200 day simple moving average of $703.63.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.46). Axon Enterprise had a net margin of 10.05% and a return on equity of 4.29%. The firm had revenue of $710.64 million for the quarter, compared to analyst estimates of $704.83 million. During the same period in the prior year, the company posted $1.45 earnings per share. The business’s revenue was up 30.6% on a year-over-year basis. Sell-side analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.